, Tracking Stock Market Picks
Enter Symbol:
Cleveland Biolabs, Inc. (CBLI) [hlAlert]

Mkt Outperform
up 5.35 %

Cleveland Biolabs, Inc. (CBLI) rated Mkt Outperform with price target $11 by Rodman & Renshaw

Posted on: Friday,  Sep 17, 2010  11:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Cleveland Biolabs, Inc. (NASDAQ: CBLI) on 09/17/2010. Previously Rodman & Renshaw rated Mkt Outperform Cleveland Biolabs, Inc. (NASDAQ:
CBLI) on 09/29/2009., when the stock price was $3.55. Since then, Cleveland Biolabs, Inc. has gained 5.35% as of 08/27/2015's recent price of $3.74.
If you would have followed the previous Rodman & Renshaw's recommendation on CBLI, you would have gained 5.35% of your investment in 2158 days.

Cleveland BioLabs, Inc. (CBLI) is a development-stage biotechnology company. The Company is focused on developing cancer treatment, tissue protection and biodefense drugs. The Company?s pipeline includes products from two primary families of compounds: protectans and curaxins. CBLI is developing protectans as drug candidates that protect healthy tissues from acute stresses such as radiation, chemotherapy and ischemia (pathologies that develop as a result of blocking blood flow to a part of the body). Curaxins are being developed as anticancer agents that could act as mono-therapy drugs or in combination with other existing anticancer therapies.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/17/2010 11:25 AM Buy
5.17 11.00
as of 12/31/2010
1 Week up  2.63 %
1 Month up  9.95 %
3 Months up  43.41 %
1 YTD up  123.56 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/29/2009 10:25 AM Buy
3.55 8.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy